MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Striatal postsynaptic dysfunction in X-linked dystonia-parkinsonism is associated with disease progression

N. Brüggemann, R.L. Rosales, J.L. Waugh, A.J. Blood, A. Domingo, M. Heldmann, R.D. Jamora, A. Münchau, L.V. Lee, I. Buchmann, C. Klein (Lübeck, Germany)

Meeting: 2016 International Congress

Abstract Number: 1650

Keywords: Dystonia: Pathophysiology, Magnetic resonance imaging(MRI), Single-photon emission computed tomography(SPECT)

Session Information

Date: Thursday, June 23, 2016

Session Title: Dystonia and Pediatric Movement Disorders

Session Time: 12:00pm-1:30pm

Objective: To assess pre- and postsynaptic dopaminergic function in X-linked dystonia-parkinsonism (XDP).

Background: X-linked dystonia-parkinsonism (XDP) is a neurodegenerative adult-onset movement disorder associated with striatal atrophy. It is unclear whether nigrostriatal dysfunction contributes to parkinsonism in this basal ganglia model disease.

Methods: We obtained a total of 10 IBZM SPECTs in 9 patients aged 42.3±9.5 years, 1 asymptomatic mutation carrier (38 years) and FP-CIT SPECTs in four patients, aged 41.5 ± 11.6 years. We also performed structural MRI in mutation carriers and 10 matched healthy controls.

Results: All patients were male and suffered from severe segmental or generalized dystonia and varying degrees of parkinsonism. IBZM SPECTs were pathologic in 8/9 symptomatic patients, and unremarkable in the asymptomatic mutation carrier [fig A and B]. Longer disease duration (rho=-0.77, P=0.016) was associated with lower IBZM binding ratios [fig A]. Visual inspection of FP-CIT SPECTs revealed slightly reduced striatal tracer uptake in 3/4 patients. In the asymptomatic mutation carrier, basal ganglia volume was intermediate between healthy Filipino controls and symptomatic XDP carriers who presented striking atrophy. [fig B].

Conclusions: Unlike Parkinson’s disease with nigrostriatal degeneration, the current study supports the hypothesis that striatal dysfunction is the primary source of both dystonia and Parkinsonian symptoms in XDP. The functional decline of postsynaptic dopaminergic neurotransmission is related to XDP disease duration and thus to ongoing neurodegeneration. Compensatory up-regulation of postsynaptic dopamine receptors into the normal range in the asymptomatic mutation carrier may be one of the mechanisms by which the brain counteracts ongoing striatal degeneration. As the disease is rapidly progressive in the first few years, the breakdown of compensatory mechanisms appears abrupt and much more pronounced than in other neurodegenerative movement disorders such as Huntington’s and Parkinson’s disease.

To cite this abstract in AMA style:

N. Brüggemann, R.L. Rosales, J.L. Waugh, A.J. Blood, A. Domingo, M. Heldmann, R.D. Jamora, A. Münchau, L.V. Lee, I. Buchmann, C. Klein. Striatal postsynaptic dysfunction in X-linked dystonia-parkinsonism is associated with disease progression [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/striatal-postsynaptic-dysfunction-in-x-linked-dystonia-parkinsonism-is-associated-with-disease-progression/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/striatal-postsynaptic-dysfunction-in-x-linked-dystonia-parkinsonism-is-associated-with-disease-progression/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley